title: Constitutively activated Notch signaling is involved in survival and apoptosis resistance of B-CLL cells.
abstract: Notch signaling is involved in tumorigenesis, but its role in B-chronic lymphocytic leukemia (B-CLL) pathogenesis is not completely defined. This study examined the expression and activation of Notch receptors in B-CLL cells and the role of Notch signaling in sustaining the survival of these cells. Our results show that B-CLL cells but not normal B cells constitutively express Notch1 and Notch2 proteins as well as their ligands Jagged1 and Jagged2. Notch signaling is constitutively activated in B-CLL cells, and its activation is further increased in B-CLL cells, which resist spontaneous apoptosis after 24-hour ex vivo culture. Notch stimulation by a soluble Jagged1 ligand increases B-CLL cell survival and is accompanied by increased nuclear factor-kappa B (NF-kappaB) activity and cellular inhibitor of apoptosis protein 2 (c-IAP2) and X-linked inhibitor of apoptosis protein (XIAP) expression. In contrast, Notch-signaling inhibition by the gamma-secretase inhibitor I (GSI; z-Leu-Leu-Nle-CHO) and the specific Notch2 down-regulation by small-interfering RNA accelerate spontaneous B-CLL cell apoptosis. Apoptotic activity of GSI is accompanied by reduction of NF-kappaB activity and c-IAP2 and XIAP expression. Overall, our findings show that Notch signaling plays a critical role in B-CLL cell survival and apoptosis resistance and suggest that it could be a novel potential therapeutic target.
authors.affiliation: Department of Clinical and Experimental Medicine, General Pathology and Immunology Section, University of Perugia, Perugia.
authors.forename: Emanuela
authors.initials: E
authors.lastname: Rosati
authors.forename: Rita
authors.initials: R
authors.lastname: Sabatini
authors.forename: Giuliana
authors.initials: G
authors.lastname: Rampino
authors.forename: Antonio
authors.initials: A
authors.lastname: Tabilio
authors.forename: Mauro
authors.initials: M
authors.lastname: Di Ianni
authors.forename: Katia
authors.initials: K
authors.lastname: Fettucciari
authors.forename: Andrea
authors.initials: A
authors.lastname: Bartoli
authors.forename: Stefano
authors.initials: S
authors.lastname: Coaccioli
authors.forename: Isabella
authors.initials: I
authors.lastname: Screpanti
authors.forename: Pierfrancesco
authors.initials: P
authors.lastname: Marconi
mesh_terms: D017209:Apoptosis; D001402:B-Lymphocytes / Q000378:metabolism; D002135:Calcium-Binding Proteins / Q000378:metabolism; D002470:Cell Survival; D015536:Down-Regulation; D006801:Humans; D051034:Inhibitor of Apoptosis Proteins / Q000378:metabolism; D036341:Intercellular Signaling Peptides and Proteins / Q000378:metabolism; D000072100:Jagged-1 Protein; D000072101:Jagged-2 Protein; D015451:Leukemia, Lymphocytic, Chronic, B-Cell / Q000378:metabolism* / Q000473:pathology*; D008565:Membrane Proteins / Q000378:metabolism; D016328:NF-kappa B / Q000378:metabolism; D034741:RNA, Small Interfering / Q000235:genetics; D051880:Receptors, Notch / Q000378:metabolism*; D000072099:Serrate-Jagged Proteins; D015398:Signal Transduction; D014407:Tumor Cells, Cultured
chemical_list: D002135:Calcium-Binding Proteins; D051034:Inhibitor of Apoptosis Proteins; D036341:Intercellular Signaling Peptides and Proteins; C000606273:JAG1 protein, human; C490504:JAG2 protein, human; D000072100:Jagged-1 Protein; D000072101:Jagged-2 Protein; D008565:Membrane Proteins; D016328:NF-kappa B; D034741:RNA, Small Interfering; D051880:Receptors, Notch; D000072099:Serrate-Jagged Proteins